K2 Principal Fund’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-101,103
| Closed | -$495K | – | 318 |
|
|
2018
Q1 | $495K | Sell |
101,103
-118,440
| -54% | -$580K | 0.03% | 183 |
|
|
2017
Q4 | $620K | Buy |
219,543
+55,033
| +33% | +$155K | 0.04% | 157 |
|
|
2017
Q3 | $485K | Hold |
164,510
| – | – | 0.03% | 157 |
|
|
2017
Q2 | $518K | Buy |
164,510
+47,535
| +41% | +$150K | 0.03% | 168 |
|
|
2017
Q1 | $468K | Buy |
116,975
+59,747
| +104% | +$239K | 0.04% | 150 |
|
|
2016
Q4 | $441K | Buy |
57,228
+42,228
| +282% | +$325K | 0.04% | 111 |
|
|
2016
Q3 | $122K | Buy |
+15,000
| New | +$122K | 0.01% | 143 |
|